- Home
- CMPX vs VACH Comparison
CMPX vs VACH Comparison
Compare CMPX & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- VACH
- Stock Information
- Founded
- CMPX 2014
- VACH 2023
- Country
- CMPX United States
- VACH United States
- Employees
- CMPX N/A
- VACH N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- VACH
- Sector
- CMPX Health Care
- VACH
- Exchange
- CMPX Nasdaq
- VACH NYSE
- Market Cap
- CMPX 291.8M
- VACH 324.2M
- IPO Year
- CMPX N/A
- VACH 2024
- Fundamental
- Price
- CMPX $2.61
- VACH $10.39
- Analyst Decision
- CMPX Strong Buy
- VACH
- Analyst Count
- CMPX 9
- VACH 0
- Target Price
- CMPX $12.67
- VACH N/A
- AVG Volume (30 Days)
- CMPX 946.0K
- VACH 108.5K
- Earning Date
- CMPX 08-11-2025
- VACH 01-01-0001
- Dividend Yield
- CMPX N/A
- VACH N/A
- EPS Growth
- CMPX N/A
- VACH N/A
- EPS
- CMPX N/A
- VACH 0.30
- Revenue
- CMPX $850,000.00
- VACH N/A
- Revenue This Year
- CMPX N/A
- VACH N/A
- Revenue Next Year
- CMPX N/A
- VACH N/A
- P/E Ratio
- CMPX N/A
- VACH $35.14
- Revenue Growth
- CMPX N/A
- VACH N/A
- 52 Week Low
- CMPX $0.77
- VACH $9.95
- 52 Week High
- CMPX $4.08
- VACH $11.20
- Technical
- Relative Strength Index (RSI)
- CMPX 60.92
- VACH N/A
- Support Level
- CMPX $2.52
- VACH N/A
- Resistance Level
- CMPX $2.71
- VACH N/A
- Average True Range (ATR)
- CMPX 0.17
- VACH 0.00
- MACD
- CMPX 0.00
- VACH 0.00
- Stochastic Oscillator
- CMPX 68.64
- VACH 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.